The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Molecular Residual Disease Detection Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global Molecular Residual Disease Detection Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1757228

No of Pages : 101

Ask Your Query

Synopsis
The global Molecular Residual Disease Detection market size was valued at USD 4815.5 million in 2022 and is forecast to a readjusted size of USD 12750 million by 2029 with a CAGR of 14.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Molecular residual lesions often refer to minimal residual lesions, which refer to a small number of cancer cells that remain in the body after cancer treatment (cancer cells that do not respond to treatment or are drug-resistant).

This report is a detailed and comprehensive analysis for global Molecular Residual Disease Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global Molecular Residual Disease Detection market size and forecasts, in consumption value ($ Million), 2018-2029
  • Global Molecular Residual Disease Detection market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
  • Global Molecular Residual Disease Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
  • Global Molecular Residual Disease Detection market shares of main players, in revenue ($ Million), 2018-2023.

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Molecular Residual Disease Detection
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace.

This report profiles key players in the global Molecular Residual Disease Detection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adaptive, Guardant Health, Invitae, Cergentis B.V and LexentBio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Molecular Residual Disease Detection market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Tumor-informed Assays
  • Tumor-agnostic Assays

Market segment by Application

  • Prognosis
  • Adjuvant Treatment Decision-Making
  • Surveillance for Postoperative Recurrence
  • Other

Market segment by players, this report covers

  • Adaptive
  • Guardant Health
  • Invitae
  • Cergentis B.V
  • LexentBio
  • Natera
  • BGI
  • Zhiben Medical
  • Burning Rock Medicine
  • Huidu Medical
  • Zhenhe Technology
  • ExactSciences

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Molecular Residual Disease Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Molecular Residual Disease Detection, with revenue, gross margin and global market share of Molecular Residual Disease Detection from 2018 to 2023.
Chapter 3, the Molecular Residual Disease Detection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Molecular Residual Disease Detection market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Residual Disease Detection.
Chapter 13, to describe Molecular Residual Disease Detection research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Molecular Residual Disease Detection
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Molecular Residual Disease Detection by Type
1.3.1 Overview: Global Molecular Residual Disease Detection Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Molecular Residual Disease Detection Consumption Value Market Share by Type in 2022
1.3.3 Tumor-informed Assays
1.3.4 Tumor-agnostic Assays
1.4 Global Molecular Residual Disease Detection Market by Application
1.4.1 Overview: Global Molecular Residual Disease Detection Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Prognosis
1.4.3 Adjuvant Treatment Decision-Making
1.4.4 Surveillance for Postoperative Recurrence
1.4.5 Other
1.5 Global Molecular Residual Disease Detection Market Size & Forecast
1.6 Global Molecular Residual Disease Detection Market Size and Forecast by Region
1.6.1 Global Molecular Residual Disease Detection Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Molecular Residual Disease Detection Market Size by Region, (2018-2029)
1.6.3 North America Molecular Residual Disease Detection Market Size and Prospect (2018-2029)
1.6.4 Europe Molecular Residual Disease Detection Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Molecular Residual Disease Detection Market Size and Prospect (2018-2029)
1.6.6 South America Molecular Residual Disease Detection Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Molecular Residual Disease Detection Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Adaptive
2.1.1 Adaptive Details
2.1.2 Adaptive Major Business
2.1.3 Adaptive Molecular Residual Disease Detection Product and Solutions
2.1.4 Adaptive Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Adaptive Recent Developments and Future Plans
2.2 Guardant Health
2.2.1 Guardant Health Details
2.2.2 Guardant Health Major Business
2.2.3 Guardant Health Molecular Residual Disease Detection Product and Solutions
2.2.4 Guardant Health Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Guardant Health Recent Developments and Future Plans
2.3 Invitae
2.3.1 Invitae Details
2.3.2 Invitae Major Business
2.3.3 Invitae Molecular Residual Disease Detection Product and Solutions
2.3.4 Invitae Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Invitae Recent Developments and Future Plans
2.4 Cergentis B.V
2.4.1 Cergentis B.V Details
2.4.2 Cergentis B.V Major Business
2.4.3 Cergentis B.V Molecular Residual Disease Detection Product and Solutions
2.4.4 Cergentis B.V Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cergentis B.V Recent Developments and Future Plans
2.5 LexentBio
2.5.1 LexentBio Details
2.5.2 LexentBio Major Business
2.5.3 LexentBio Molecular Residual Disease Detection Product and Solutions
2.5.4 LexentBio Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 LexentBio Recent Developments and Future Plans
2.6 Natera
2.6.1 Natera Details
2.6.2 Natera Major Business
2.6.3 Natera Molecular Residual Disease Detection Product and Solutions
2.6.4 Natera Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Natera Recent Developments and Future Plans
2.7 BGI
2.7.1 BGI Details
2.7.2 BGI Major Business
2.7.3 BGI Molecular Residual Disease Detection Product and Solutions
2.7.4 BGI Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 BGI Recent Developments and Future Plans
2.8 Zhiben Medical
2.8.1 Zhiben Medical Details
2.8.2 Zhiben Medical Major Business
2.8.3 Zhiben Medical Molecular Residual Disease Detection Product and Solutions
2.8.4 Zhiben Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Zhiben Medical Recent Developments and Future Plans
2.9 Burning Rock Medicine
2.9.1 Burning Rock Medicine Details
2.9.2 Burning Rock Medicine Major Business
2.9.3 Burning Rock Medicine Molecular Residual Disease Detection Product and Solutions
2.9.4 Burning Rock Medicine Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Burning Rock Medicine Recent Developments and Future Plans
2.10 Huidu Medical
2.10.1 Huidu Medical Details
2.10.2 Huidu Medical Major Business
2.10.3 Huidu Medical Molecular Residual Disease Detection Product and Solutions
2.10.4 Huidu Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Huidu Medical Recent Developments and Future Plans
2.11 Zhenhe Technology
2.11.1 Zhenhe Technology Details
2.11.2 Zhenhe Technology Major Business
2.11.3 Zhenhe Technology Molecular Residual Disease Detection Product and Solutions
2.11.4 Zhenhe Technology Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Zhenhe Technology Recent Developments and Future Plans
2.12 ExactSciences
2.12.1 ExactSciences Details
2.12.2 ExactSciences Major Business
2.12.3 ExactSciences Molecular Residual Disease Detection Product and Solutions
2.12.4 ExactSciences Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 ExactSciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Molecular Residual Disease Detection Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Molecular Residual Disease Detection by Company Revenue
3.2.2 Top 3 Molecular Residual Disease Detection Players Market Share in 2022
3.2.3 Top 6 Molecular Residual Disease Detection Players Market Share in 2022
3.3 Molecular Residual Disease Detection Market: Overall Company Footprint Analysis
3.3.1 Molecular Residual Disease Detection Market: Region Footprint
3.3.2 Molecular Residual Disease Detection Market: Company Product Type Footprint
3.3.3 Molecular Residual Disease Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Molecular Residual Disease Detection Consumption Value and Market Share by Type (2018-2023)
4.2 Global Molecular Residual Disease Detection Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Molecular Residual Disease Detection Consumption Value Market Share by Application (2018-2023)
5.2 Global Molecular Residual Disease Detection Market Forecast by Application (2024-2029)
6 North America
6.1 North America Molecular Residual Disease Detection Consumption Value by Type (2018-2029)
6.2 North America Molecular Residual Disease Detection Consumption Value by Application (2018-2029)
6.3 North America Molecular Residual Disease Detection Market Size by Country
6.3.1 North America Molecular Residual Disease Detection Consumption Value by Country (2018-2029)
6.3.2 United States Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
6.3.3 Canada Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
6.3.4 Mexico Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Molecular Residual Disease Detection Consumption Value by Type (2018-2029)
7.2 Europe Molecular Residual Disease Detection Consumption Value by Application (2018-2029)
7.3 Europe Molecular Residual Disease Detection Market Size by Country
7.3.1 Europe Molecular Residual Disease Detection Consumption Value by Country (2018-2029)
7.3.2 Germany Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
7.3.3 France Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
7.3.5 Russia Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
7.3.6 Italy Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Molecular Residual Disease Detection Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Molecular Residual Disease Detection Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Molecular Residual Disease Detection Market Size by Region
8.3.1 Asia-Pacific Molecular Residual Disease Detection Consumption Value by Region (2018-2029)
8.3.2 China Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
8.3.3 Japan Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
8.3.4 South Korea Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
8.3.5 India Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
8.3.7 Australia Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
9 South America
9.1 South America Molecular Residual Disease Detection Consumption Value by Type (2018-2029)
9.2 South America Molecular Residual Disease Detection Consumption Value by Application (2018-2029)
9.3 South America Molecular Residual Disease Detection Market Size by Country
9.3.1 South America Molecular Residual Disease Detection Consumption Value by Country (2018-2029)
9.3.2 Brazil Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
9.3.3 Argentina Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Molecular Residual Disease Detection Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Molecular Residual Disease Detection Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Molecular Residual Disease Detection Market Size by Country
10.3.1 Middle East & Africa Molecular Residual Disease Detection Consumption Value by Country (2018-2029)
10.3.2 Turkey Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
10.3.4 UAE Molecular Residual Disease Detection Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Molecular Residual Disease Detection Market Drivers
11.2 Molecular Residual Disease Detection Market Restraints
11.3 Molecular Residual Disease Detection Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Molecular Residual Disease Detection Industry Chain
12.2 Molecular Residual Disease Detection Upstream Analysis
12.3 Molecular Residual Disease Detection Midstream Analysis
12.4 Molecular Residual Disease Detection Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock